• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.

作者信息

Patrono Carlo, Bachmann Fedor, Baigent Colin, Bode Christopher, De Caterina Raffaele, Charbonnier Bernard, Fitzgerald Desmond, Hirsh Jack, Husted Steen, Kvasnicka Jan, Montalescot Gilles, García Rodríguez Luis Alberto, Verheugt Freek, Vermylen Jozef, Wallentin Lars, Priori Silvia G, Alonso Garcia Maria Angeles, Blanc Jean Jacques, Budaj Andrzej, Cowie Martin, Dean Veronica, Deckers Jaap, Fernández Burgos Enrique, Lekakis John, Lindahl Bertil, Mazzotta Gianfranco, Morais João, Oto Ali, Smiseth Otto A, Morais João, Deckers Jaap, Ferreira Rafael, Mazzotta Gianfranco, Steg Philippe Gabriel, Teixeira Frederico, Wilcox Robert

机构信息

ESC Task Force on Antiplatelets, University of Rome La Sapienza, II Facoltà di Medicina e Chirurgia, Via di Grottarossa, 1035, 00189 Roma, Italy.

出版信息

Eur Heart J. 2004 Jan;25(2):166-81. doi: 10.1016/j.ehj.2003.10.013.

DOI:10.1016/j.ehj.2003.10.013
PMID:14720534
Abstract
摘要

相似文献

1
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.
Eur Heart J. 2004 Jan;25(2):166-81. doi: 10.1016/j.ehj.2003.10.013.
2
Antiplatelet effect of aspirin in patients with coronary artery disease.阿司匹林对冠状动脉疾病患者的抗血小板作用。
Dan Med J. 2012 Sep;59(9):B4506.
3
Platelets and antiplatelet therapy in patients with diabetes mellitus.糖尿病患者的血小板与抗血小板治疗
J Invasive Cardiol. 2003 May;15(5):264-9.
4
[Chinese Society of Cardiology and Chinese College of Cardiovascular Physicians Expert Consensus statement on dual antiplatelet therapy in patients with coronary artery disease].[中国心血管病学会和中国心血管内科医师学会关于冠心病患者双联抗血小板治疗的专家共识声明]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 May 24;49(5):432-454. doi: 10.3760/cma.j.cn112148-20210125-00088.
5
Antiplatelet agents for the treatment and prevention of atherothrombosis.抗血小板药物治疗和预防动脉粥样硬化血栓形成。
Eur Heart J. 2011 Dec;32(23):2922-32. doi: 10.1093/eurheartj/ehr373. Epub 2011 Oct 20.
6
Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).冠心病患者抗血小板治疗的围手术期管理：血栓形成和止血研究学会（GTH）围手术期止血工作组、奥地利麻醉学、复苏和重症监护学会（ÖGARI）围手术期凝血工作组和欧洲心脏病学会（ESC）血栓工作组成员的联合立场文件。
Thromb Haemost. 2011 May;105(5):743-9. doi: 10.1160/TH10-04-0217. Epub 2011 Mar 24.
7
Oral Antiplatelet Therapy in Coronary Disease.冠心病的抗血小板治疗。
Am J Ther. 2017 Nov/Dec;24(6):e744-e750. doi: 10.1097/MJT.0000000000000378.
8
The pursuit of clinically relevant measures of platelet function after antiplatelet drug therapy.抗血小板药物治疗后血小板功能临床相关指标的研究。
J Am Coll Cardiol. 2008 Dec 9;52(24):1978-80. doi: 10.1016/j.jacc.2008.08.053.
9
Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes.冠状动脉疾病和糖尿病患者的血小板与抗血小板治疗
Semin Thromb Hemost. 2016 Apr;42(3):234-41. doi: 10.1055/s-0036-1571308. Epub 2016 Feb 17.
10
Platelet-vessel wall interactions and drug effects.血小板与血管壁的相互作用及药物作用
Pharmacol Ther. 2016 Nov;167:74-84. doi: 10.1016/j.pharmthera.2016.07.008. Epub 2016 Aug 1.

引用本文的文献

1
Dual antiplatelet therapy in GI-bleed patients with extensive coronary artery disease history: a systematic review.有广泛冠状动脉疾病史的胃肠道出血患者的双重抗血小板治疗：一项系统评价
Ann Med Surg (Lond). 2025 Apr 25;87(6):3715-3735. doi: 10.1097/MS9.0000000000002833. eCollection 2025 Jun.
2
polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population.在南方汉族人群中，川崎病患者的多态性（rs7251246 T > C）、冠状动脉瘤和血栓形成。
Front Immunol. 2023 Jun 19;14:1184162. doi: 10.3389/fimmu.2023.1184162. eCollection 2023.
3
The scale of scientific evidence behind the current ESC clinical guidelines.
当前欧洲心脏病学会临床指南背后的科学证据规模。
Int J Cardiol Heart Vasc. 2023 Jan 17;45:101175. doi: 10.1016/j.ijcha.2023.101175. eCollection 2023 Apr.
4
Prognostic nutritional index value in the prognosis of Kawasaki disease with coronary artery lesions.川崎病合并冠状动脉病变预后中的预后营养指数值
Front Nutr. 2023 Feb 1;10:1075619. doi: 10.3389/fnut.2023.1075619. eCollection 2023.
5
Retrospective cohort study to determine the effect of preinjury antiplatelet or anticoagulant therapy on mortality in patients with major trauma.一项回顾性队列研究，以确定受伤前抗血小板或抗凝治疗对严重创伤患者死亡率的影响。
Front Med (Lausanne). 2023 Jan 9;9:1089219. doi: 10.3389/fmed.2022.1089219. eCollection 2022.
6
Non-acute chest pain in primary care; referral rates, communication and guideline adherence: a cohort study using routinely collected health data.基层医疗中非急性胸痛；转诊率、沟通和指南遵循情况：一项使用常规收集健康数据的队列研究。
BMC Prim Care. 2022 Dec 22;23(1):336. doi: 10.1186/s12875-022-01939-w.
7
Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease.用于冠状动脉疾病二级预防的阿司匹林治疗的个体化分配
Front Cardiovasc Med. 2022 Sep 27;9:1004473. doi: 10.3389/fcvm.2022.1004473. eCollection 2022.
8
Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.川崎病患儿不同大小和出现时间的冠状动脉瘤的危险因素及冠状动脉结局
Front Cardiovasc Med. 2022 Sep 9;9:969495. doi: 10.3389/fcvm.2022.969495. eCollection 2022.
9
Low dose aspirin associated with greater bone mineral density in older adults.低剂量阿司匹林与老年人更高的骨密度有关。
Sci Rep. 2022 Sep 1;12(1):14887. doi: 10.1038/s41598-022-19315-0.
10
Response to clopidogrel in patients undergoing lower extremity revascularization.下肢血运重建患者对氯吡格雷的反应。
Vascular. 2023 Dec;31(6):1110-1116. doi: 10.1177/17085381221103417. Epub 2022 May 19.